Publications by authors named "Rachel Erlich"

Claim this Profile
I
Insights of Clinical Significance From 109 695 Solid Tumor Tissue-Based Comprehensive Genomic Profiles.
Andreas M Heilmann, Jonathan W Riess, Margaret McLaughlin-Drubin, Richard S P Huang, Meghann Hjulstrom, Rachel L Erlich

Oncologist· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinoma.
Matthew Margolis, Tyler Janovitz, Jason Laird, Douglas A Mata, Meagan Montesion, Rachel Erlich

Mod Pathol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples.
Hatim Husain, Dean C Pavlick, Bernard J Fendler, Russell W Madison, Brennan Decker, Rachel L Erlich

JCO Precis Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers.
Andrew Rankin, Adrienne Johnson, Alison Roos, Geoffrey Kannan, Jeffrey Knipstein, Rachel Erlich

Oncologist· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNA.
Saranya Akumalla, Russell Madison, Douglas I Lin, Alexa B Schrock, Evgeny Yakirevich, Rachel L Erlich

Oncology· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN.
Marie Morfouace, Aleksandra Stevovic, Marie Vinches, Vassilis Golfinopoulos, Dexter X Jin, Rachel Erlich

ESMO Open· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer.
Richard S P Huang, Xinyan Li, James Haberberger, Ethan Sokol, Eric Severson, Rachel Erlich

Oncologist· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV- Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets.
Erik A Williams, Adrienne J Werth, Radwa Sharaf, Meagan Montesion, Ethan S Sokol, Rachel Erlich

JCO Precis Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the Gene Have Durable Responses to ALK Kinase Inhibitors.
Alexa B Schrock, Russell Madison, Mark Rosenzweig, Justin M Allen, Rachel L Erlich

Lung Cancer (Auckl)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.
Andge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, Yuri Trunin, Alexander Savateev, Rachel L Erlich

Oncologist· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association.
Douglas I Lin, Justin M Allen, Jonathan L Hecht, Jonathan K Killian, Nhu T Ngo, Rachel L Erlich

Mod Pathol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel R1004G Mutation.
Lisa Pei Chu, Debra Franck, Christine A Parachoniak, Jeffrey P Gregg, Michael G Moore, Rachel L Erlich

Oncologist· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib.
Mohammed Hassan, Erin Butler, Raphael Wilson, Angshumoy Roy, Yanbin Zheng, Rachel Erlich

Cold Spring Harb Mol Case Stud· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective.
Mitchell Reitsma, John Fox, Pierre Vanden Borre, Matthew Cavanaugh, Yakov Chudnovsky, Rachel L Erlich

J Manag Care Spec Pharm· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling.
Katherine Tarlock, Shan Zhong, Yuting He, Rhonda Ries, Eric Severson, Rachel Erlich

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy.
Erica L Gornstein, Sara Sandefur, Jon H Chung, Laurie M Gay, Oliver Holmes, Rachel L Erlich

Clin Breast Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
Adrienne Johnson, Eric Severson, Laurie Gay, Jo-Anne Vergilio, Julia Elvin, Rachel Erlich

Oncologist· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TMPRSS2-ERG fusions unexpectedly identified in men initially diagnosed with nonprostatic malignancies.
Primo N Lara, Andreas M Heilmann, Julia A Elvin, Mamta Parikh, Ralph de Vere White, Rachel Erlich

JCO Precis Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response of a Metastatic Breast Carcinoma With a Previously Uncharacterized ERBB2 G776V Mutation to Human Epidermal Growth Factor Receptor 2-Targeted Therapy.
Yakov Chudnovsky, Runjun D Kumar, Alexa B Schrock, Caitlin Connelly, Kyle Gowen, Rachel L Erlich

JCO Precis Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an variant.
Christine A Parachoniak, Andrew Rankin, Bernadette Gaffney, Ryan Hartmaier, Dan Spritz, Rachel L Erlich

Cold Spring Harb Mol Case Stud· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of advanced infantile myofibromatosis harboring a novel MYH10-RET fusion.
Mark Rosenzweig, Siraj M Ali, Victor Wong, Alexa B Schrock, Theodore W Laetsch, Rachel L Erlich

Pediatr Blood Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of an Fusion in Colorectal Carcinoma by Hybrid Capture-Based Assay of Circulating Tumor DNA.
Andrea Z Lai, Alexa B Schrock, Rachel L Erlich, Jeffrey S Ross, Vincent A Miller

Oncologist· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Profiling of Circulating Tumor DNA in Relapsed EGFR-mutated Lung Adenocarcinoma Reveals an Acquired FGFR3-TACC3 Fusion.
Justin M Allen, Alexa B Schrock, Rachel L Erlich, Vincent A Miller, Philip J Stephens

Clin Lung Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.
Pierre Vanden Borre, Alexa B Schrock, Peter M Anderson, John C Morris, Andreas M Heilmann, Rachel L Erlich

Oncologist· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra.
Juliann Chmielecki, Mark Bailey, Jie He, Julia Elvin, Jo-Anne Vergilio, Rachel L Erlich

Cancer Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis